Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharma4ever A/S
A/S
Active
Advertising protection
CVR 36436573
Hørkær 24, 2730
Herlev
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2014 · 11 years old
17 employees
www.pharma4ever.com
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
Pharma4ever A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
20M
15M
10M
5M
0M
2021: 9M
9M
2021
2022: 13M (+44% vs 2021)
13M
+44%
2022
2023: 15M (+15% vs 2022)
15M
+15%
2023
2024: 15M (0% vs 2023)
15M
0%
2024
2025: 16M (+7% vs 2024)
16M
+7%
2025
EBITDA
DKK millions
6M
5M
3M
2M
0M
2021: 2M
2M
2021
2022: 3M (+50% vs 2021)
3M
+50%
2022
2023: 5M (+67% vs 2022)
5M
+67%
2023
2024: 3M (-40% vs 2023)
3M
-40%
2024
2025: 3M (0% vs 2024)
3M
0%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
16.333
15.476
15.279
13.010
8.911
Staff expenses
-12.850
-12.368
-10.203
-9.565
-6.676
EBITDA
3.483
3.108
5.076
3.445
2.235
Depreciation & amort.
-0
-0
-0
-25
-41
EBIT
3.483
3.108
5.075
3.420
2.194
Net financials
1
-5
-3
-12
-3
Profit before tax
3.484
3.102
5.073
3.408
2.191
Tax
769
686
1.129
753
485
Net profit
2.715
2.416
3.944
2.655
1.706
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
9.734
8.762
9.779
6.251
4.875
Equity
3.215
2.916
4.528
3.235
2.329
Long-term debt
0
0
0
0
0
Short-term debt
6.519
5.845
5.245
3.011
2.543
Total debt
6.519
5.845
5.245
3.011
2.543
Financial ratios
5-year trend
EBITDA margin (of gross profit)
21,3 %
This company
2021
2025
Equity ratio
33,0 %
This company
38,2 %
Market median
This company
Market median
14% below market
2021
2025
Return on equity
84,4 %
This company
18,4 %
Market median
This company
Market median
359% above market
2021
2025
Net profit margin (of gross profit)
16,6 %
This company
2021
2025
Asset turnover (of gross profit)
1,68×
This company
2021
2025
Debt / equity
2,03×
This company
0,62×
Market median
This company
Market median
227% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharma4ever A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
